We then demonstrated that treatment with ERK or MEK inhibitors (LY3214996 or GSK1120212, respectively) attenuated the effect of YTHDC1 on suppressing renal cancer cell proliferation (Fig. 3G J). This evidence concerns the gene YTHDC1 and renal carcinoma.